AC-262 (Accadrine): The Natty Plus SARM Revolution

AC-262: The Perfect Partial Agonist

I’ve run bloodwork on hundreds of compounds, but AC-262 stands out as the most intelligent SARM design I’ve encountered. While other SARMs hammer your androgen receptors with full agonism — causing predictable suppression and side effects — AC-262 operates as a partial agonist with surgical precision. Only 27% of testosterone’s androgenic activity, but 66% of its anabolic power. This isn’t marketing fluff. This is the exact receptor binding profile that makes AC-262 the cornerstone of Connor Murphy’s Natty Plus Protocol.

Connor doubled his natural testosterone from 340 to 700 ng/dL in 11 days using this protocol. He gained 20 pounds of mostly lean mass in the first couple months. From 157 pounds at 6’3″ to 220 pounds over three years — reacquiring his peak physique without the obsessive-compulsive behaviors that plague natural bodybuilders. AC-262 made this possible because it doesn’t shut you down like conventional SARMs.

Why Partial Agonism Changes Everything

Most people don’t understand the difference between full and partial androgen receptor agonists. LGD-4033 and RAD-140 are full agonists — they activate androgen receptors at 100% capacity. Your body interprets this as a massive hormone influx and responds by shutting down natural testosterone production. Classic negative feedback loop.

AC-262 operates differently. As a partial agonist, it activates androgen receptors to only 27% of testosterone’s strength. Your hypothalamic-pituitary-gonadal axis doesn’t perceive this as hormonal overload. Instead of suppressing your natural production, AC-262 can actually support it by providing mild androgenic stimulation without triggering shutdown mechanisms.

I’ve seen this repeatedly in bloodwork. Guys running AC-262 maintain their natural testosterone levels throughout their cycles. Some even see increases, like Connor experienced. Compare this to LGD-4033, where total testosterone typically drops 40-60% within weeks, or RAD-140, which can suppress you harder than some steroids.

The Anabolic-Androgenic Ratio Scam

SARM companies love throwing around anabolic-androgenic ratios. “10:1 anabolic to androgenic!” they claim. These numbers are meaningless marketing. They’re derived from rat studies measuring muscle growth versus prostate growth — completely irrelevant to human physiology and suppression potential.

AC-262’s real-world profile matters more than any ratio. In human studies, subjects experienced significant muscle growth and strength increases without the androgenic side effects seen with testosterone or stronger SARMs. No hair loss, no prostate enlargement, minimal impact on lipids. This isn’t because of some magical ratio — it’s because partial agonism provides anabolic benefits while avoiding the full receptor activation that causes problems.

Connor Murphy’s AC-262 Results

Connor’s transformation represents the perfect AC-262 case study. Starting from a depleted state after his 40-day fast at 157 pounds, he needed compounds that would support recovery without causing additional stress to his endocrine system.

The testosterone increase from 340 to 700 ng/dL in 11 days wasn’t just from AC-262 — the Natty Plus Protocol includes multiple testosterone-supporting compounds. But AC-262 provided the anabolic foundation without suppression. This allowed his natural hormone optimization to work synergistically rather than being undermined by receptor overactivation.

His 15x growth hormone increase (from one blood test to the next) demonstrates how partial agonism can enhance other anabolic pathways. When you’re not suppressing your natural hormone production, other enhancement strategies work better. AC-262 creates an environment where your body can optimize rather than compensate.

Twenty pounds of mostly lean mass in the first couple months reflects AC-262’s steady anabolic effects. Unlike the rapid water weight and glycogen supercompensation you see with stronger SARMs, AC-262 promotes gradual, sustainable muscle growth. The kind of gains you keep when you cycle off.

The Year-Round Advantage

Connor maintains his physique year-round on the Natty Plus Protocol without obsessive behaviors. No more carrying scales to restaurants or panicking about missed training days. AC-262’s minimal suppression allows for extended use without the need for post-cycle therapy or extended breaks.

This is the key difference between AC-262 and traditional SARMs. LGD-4033 and RAD-140 require cycling — 8-12 weeks on, 4-8 weeks off minimum. Many users need PCT to recover their natural testosterone. AC-262 can be run for months without significant suppression, making it suitable for long-term physique maintenance rather than short bursts of enhancement.

Dosing AC-262 for Optimal Results

Based on available research and user reports, effective AC-262 dosing ranges from 10-30mg daily. Unlike more potent SARMs where “more is better” quickly becomes “more is worse,” AC-262’s partial agonism provides a forgiving dose-response curve.

Start at 10mg daily for the first week to assess tolerance. Most users find 15-20mg daily provides optimal results without side effects. Advanced users occasionally push to 30mg, but the additional benefits are minimal compared to the increased cost.

AC-262 has a half-life of approximately 4-6 hours, so split dosing provides more stable blood levels. Take 10mg in the morning and 10mg in the afternoon rather than 20mg at once. This maintains consistent partial agonism throughout the day.

Timing and Stacking Considerations

AC-262 works excellently as a standalone compound, but it truly shines in the Natty Plus Protocol stack. Combined with natural testosterone optimizers, growth hormone releasing peptides, and recovery enhancement compounds, AC-262 provides the anabolic foundation that allows other strategies to work more effectively.

Take AC-262 with food to improve absorption. The compound is lipophilic, so taking it with dietary fat enhances bioavailability. Avoid taking it immediately pre-workout — the mild nature means you won’t notice acute performance benefits like you would with aggressive pre-workout stimulants.

AC-262 vs. Traditional SARMs

The comparison between AC-262 and full agonist SARMs illustrates why partial agonism represents superior design for long-term enhancement. Let me break down the key differences based on bloodwork, user reports, and clinical data.

LGD-4033: The Suppression King

LGD-4033 (Ligandrol) was among the first widely available SARMs, and its full agonist activity creates predictable problems. Users typically see 40-60% suppression of natural testosterone within 2-3 weeks at standard doses (5-10mg daily). Total testosterone often drops below 300 ng/dL by week 6-8.

The muscle-building effects are undeniable — users commonly gain 8-15 pounds during an 8-week cycle. But the suppression requires post-cycle therapy with SERMs like tamoxifen or clomiphene. Recovery takes 4-8 weeks minimum, during which users often lose significant gains.

LGD-4033 also impacts lipid profiles more significantly than AC-262. HDL cholesterol typically drops 20-40%, while LDL increases. These changes reverse after the cycle, but they represent additional stress on cardiovascular health.

RAD-140: The Aggressive Option

RAD-140 (Testolone) provides the most aggressive muscle-building effects among SARMs, but at a significant cost. Its high binding affinity and full agonist activity can suppress testosterone harder than some steroids. I’ve seen bloodwork showing complete shutdown — testosterone below 50 ng/dL — after 6-8 weeks at 10-20mg daily.

RAD-140 also demonstrates concerning neurotoxicity signals in some users. Mood changes, aggression, and sleep disturbances occur more frequently than with other SARMs. These effects likely relate to its high CNS penetration and full receptor activation in brain tissue.

While RAD-140 might build more muscle faster than AC-262, the recovery time and potential side effects make it unsuitable for the Natty Plus philosophy. If you need PCT and weeks of recovery, you’re no longer maintaining natural hormone production.

Why AC-262 Wins Long-Term

AC-262’s 66% anabolic activity relative to testosterone provides substantial muscle-building effects without the dramatic suppression. Users report steady strength gains and improved recovery without the mood swings or energy crashes associated with stronger SARMs.

The sustainability factor cannot be overstated. While LGD-4033 or RAD-140 might produce faster initial results, AC-262 allows continuous progress without cycling off. Over 12 months, consistent AC-262 use often produces superior results compared to intermittent cycles of stronger compounds.

Joint comfort represents another advantage. AC-262’s partial agonism appears to support joint health rather than causing the joint pain some users experience with full agonist SARMs. This might relate to its effects on collagen synthesis or inflammatory markers.

The Science Behind Partial Agonism

Understanding why partial agonists work differently requires examining androgen receptor pharmacology. When testosterone or a full agonist SARM binds to androgen receptors, it causes maximum conformational change in the receptor protein. This triggers full activation of downstream signaling pathways — both beneficial anabolic effects and problematic side effects.

Partial agonists like AC-262 bind to the same receptors but cause incomplete conformational change. This results in submaximal activation — enough to trigger anabolic signaling but not enough to overwhelm regulatory mechanisms. The receptor remains responsive to natural hormone fluctuations rather than being locked in the “on” position.

This mechanism explains why AC-262 doesn’t suppress testosterone production as severely. Your hypothalamus and pituitary don’t perceive the partial activation as hormonal excess. Natural luteinizing hormone and follicle-stimulating hormone production continue, maintaining testicular function. This is a textbook application of the Tony Huge Laws of Biochemistry Physics — the principle of receptor occupancy and downstream signaling efficiency dictates that partial activation avoids the negative feedback loops triggered by full saturation.

Tissue-Selective Benefits

Partial agonism also provides tissue selectivity advantages. Different tissues express varying levels of androgen receptors and co-activators. Full agonists activate all tissues maximally, causing both desired effects (muscle growth) and undesired effects (prostate enlargement, hair loss).

AC-262’s partial activation preferentially benefits tissues with high receptor density and favorable co-activator profiles — primarily skeletal muscle. Tissues more sensitive to androgenic side effects receive insufficient activation to trigger problems. This creates a wider therapeutic window between beneficial and harmful effects.

Real-World Applications and Protocols

AC-262 fits into multiple enhancement strategies beyond the Natty Plus Protocol. Its mild nature and lack of suppression make it suitable for athletes subject to drug testing (though it would likely be detected if specifically tested for), older individuals concerned about hormone suppression, and anyone wanting sustainable enhancement without cycling requirements.

Recomposition Protocols

AC-262 excels during body recomposition — simultaneous fat loss and muscle gain. Its anabolic effects help preserve muscle during caloric deficits while potentially improving fat oxidation through enhanced insulin sensitivity. Many users report improved body composition even without dramatic scale weight changes.

For recomposition, combine AC-262 (15-20mg daily) with a moderate caloric deficit (300-500 calories below maintenance) and consistent resistance training. The compound provides enough anabolic stimulus to maintain or even build muscle while in a deficit — something extremely difficult for natural trainees.

Recovery and Injury Prevention

AC-262’s effects on recovery extend beyond muscle growth. Users consistently report faster recovery between training sessions, reduced muscle soreness, and improved training capacity. These benefits likely relate to enhanced protein synthesis and potentially improved sleep quality.

Some users incorporate AC-262 specifically for injury recovery or prevention. While not a panacea, the compound’s effects on tissue repair and collagen synthesis may accelerate healing from minor injuries. The lack of suppression makes it suitable for extended use during rehabilitation periods.

Interesting Perspectives

While AC-262 is primarily discussed in the context of muscle building, its partial agonist profile opens doors to unconventional applications. The principle of submaximal receptor activation to avoid systemic shutdown could be applied to other hormonal pathways beyond androgens. For instance, a partial agonist approach to thyroid or cortisol modulation might yield similar benefits of gentle nudging without crashing endogenous production—a concept that aligns with the broader biohacking philosophy of enhancing organ reserve rather than replacing function.

Furthermore, AC-262’s mechanism suggests a potential role in “androgen priming” for older populations. Instead of full testosterone replacement therapy (TRT) with its attendant risks, a partial agonist like AC-262 could provide enough anabolic support to combat sarcopenia and improve metabolic health without completely shutting down the user’s remaining HPG axis function. This could be a bridge therapy for those with borderline-low testosterone who wish to avoid lifelong TRT commitment.

From a nootropic and cognitive standpoint, the androgen receptor is expressed in the brain and influences mood, motivation, and neuroprotection. The selective, partial activation by AC-262, with its reportedly lower incidence of mood swings and aggression compared to full agonists like RAD-140, hints at a possible application for supporting cognitive drive and resilience in aging or stressed individuals, without the psychiatric side-effect profile of stronger androgens. This cross-domain thinking—applying muscle-building pharmacology to brain health—is where the next generation of intelligent biohacking is headed.

Source Quality and Legitimacy Concerns

AC-262’s relative obscurity compared to LGD-4033 and RAD-140 creates sourcing challenges. Many suppliers don’t carry it, and some that do provide underdosed or contaminated products. The mild effects make underdosing less obvious than with stronger compounds.

Demand third-party testing certificates of analysis for any AC-262 purchase. Reputable suppliers provide comprehensive testing for purity, identity, and common contaminants. Avoid suppliers offering AC-262 significantly cheaper than established vendors — it’s likely underdosed or fake.

The liquid versus powder debate applies to AC-262 like other SARMs. Liquid preparations often provide better dosing accuracy for the small amounts required, while powder allows for custom dosing and longer storage. Both can be legitimate if properly prepared and tested.

Legal Considerations

AC-262 exists in the same legal gray area as other research SARMs. It’s not approved for human consumption by the FDA but remains legal to purchase for research purposes. This situation could change as authorities focus more attention on SARMs generally. The landscape for research chemicals is evolving, as discussed in our article on RFK Jr. Peptide Deregulation 2026.

International shipping faces increasing restrictions. Some countries specifically ban SARM importation, while others scrutinize packages from known research chemical suppliers. Domestic suppliers often provide more reliable delivery, though selection may be limited.

The Future of Intelligent Enhancement

AC-262 represents what intelligent enhancement looks like — compounds designed to provide benefits while minimizing downsides. Rather than chasing maximum potency regardless of consequences, partial agonists offer sustainable improvement that works with your physiology rather than against it.

This approach aligns perfectly with the Natty Plus philosophy Connor and I developed. Enhancement doesn’t require sacrificing health or natural hormone production. Sometimes the most powerful tool is the one that doesn’t break your body in the process.

As more people experience AC-262’s benefits without the typical SARM side effects, demand will likely increase for similar partial agonist compounds. The pharmaceutical industry is already developing selective androgen receptor modulators with partial agonist properties for therapeutic use.

Building Your AC-262 Protocol

Start conservative with AC-262. Begin at 10mg daily for the first week, monitoring for any adverse effects. Most users tolerate 15-20mg daily well, providing noticeable benefits without significant side effects.

Track your progress objectively — body weight, strength metrics, body composition if possible. AC-262’s mild nature means changes occur gradually rather than dramatically. Keep training and nutrition consistent to accurately assess the compound’s effects.

Consider bloodwork after 4-6 weeks to confirm minimal suppression. Basic hormone panels (total testosterone, LH, FSH) provide adequate monitoring for most users. More comprehensive panels including liver enzymes and lipids offer additional safety confirmation.

AC-262 changed Connor’s physique and maintained his natural hormone production. It can do the same for anyone willing to prioritize intelligent enhancement over maximum aggression. Already enhanced. Now optimize.